Emílio Alves Odebrecht

Recepta Biopharma SA researches and develops drugs for cancer treatment. It is a biotechnology company which is engaged in the research, development, production and marketing of human antibodies for the diagnosis and treatment of human cancer. The company was founded in 2006 and is headquartered in Sao Paulo, Brazil.

Recepta Biopharma SA researches and develops drugs for cancer treatment. It is a biotechnology company which is engaged in the research, development, production and marketing of human antibodies for the diagnosis and treatment of human cancer. The company was founded in 2006 and is headquartered in Sao Paulo, Brazil.

Recepta Biopharma SA researches and develops drugs for cancer treatment. It is a biotechnology company which is engaged in the research, development, production and marketing of human antibodies for the diagnosis and treatment of human cancer. The company was founded in 2006 and is headquartered in Sao Paulo, Brazil.

Recepta Biopharma SA researches and develops drugs for cancer treatment. It is a biotechnology company which is engaged in the research, development, production and marketing of human antibodies for the diagnosis and treatment of human cancer. The company was founded in 2006 and is headquartered in Sao Paulo, Brazil.

Fundação Odebrecht focuses on the youth and family development in order to create solutions together with local communities, based on their capabilities and needs. The company was founded by Norberto Odebrecht in 1965 and is headquartered in Salvador, Brazil.

Fundação Odebrecht focuses on the youth and family development in order to create solutions together with local communities, based on their capabilities and needs. The company was founded by Norberto Odebrecht in 1965 and is headquartered in Salvador, Brazil.

Recepta Biopharma SA researches and develops drugs for cancer treatment. It is a biotechnology company which is engaged in the research, development, production and marketing of human antibodies for the diagnosis and treatment of human cancer. The company was founded in 2006 and is headquartered in Sao Paulo, Brazil.

Recepta Biopharma SA researches and develops drugs for cancer treatment. It is a biotechnology company which is engaged in the research, development, production and marketing of human antibodies for the diagnosis and treatment of human cancer. The company was founded in 2006 and is headquartered in Sao Paulo, Brazil.

Fundação Odebrecht focuses on the youth and family development in order to create solutions together with local communities, based on their capabilities and needs. The company was founded by Norberto Odebrecht in 1965 and is headquartered in Salvador, Brazil.

Fundação Odebrecht focuses on the youth and family development in order to create solutions together with local communities, based on their capabilities and needs. The company was founded by Norberto Odebrecht in 1965 and is headquartered in Salvador, Brazil.

Fundação Odebrecht focuses on the youth and family development in order to create solutions together with local communities, based on their capabilities and needs. The company was founded by Norberto Odebrecht in 1965 and is headquartered in Salvador, Brazil.

Fundação Odebrecht focuses on the youth and family development in order to create solutions together with local communities, based on their capabilities and needs. The company was founded by Norberto Odebrecht in 1965 and is headquartered in Salvador, Brazil.

Fundação Odebrecht focuses on the youth and family development in order to create solutions together with local communities, based on their capabilities and needs. The company was founded by Norberto Odebrecht in 1965 and is headquartered in Salvador, Brazil.

Fundação Odebrecht focuses on the youth and family development in order to create solutions together with local communities, based on their capabilities and needs. The company was founded by Norberto Odebrecht in 1965 and is headquartered in Salvador, Brazil.

Recepta Biopharma SA researches and develops drugs for cancer treatment. It is a biotechnology company which is engaged in the research, development, production and marketing of human antibodies for the diagnosis and treatment of human cancer. The company was founded in 2006 and is headquartered in Sao Paulo, Brazil.